Despite the fact that these findings were made in tumor cells that spontaneously overexpressed GPX3 and that high GPX3 expression was associated with poorer overall survival in patients with ovarian cancer and with increased tumor stage [109], all direct manipulations with GPX3 overexpression conversely indicate the potential safety of such manipulation from the perspective of carcinogenesis. This evidence concerns the gene GPX3 and ovarian carcinoma.